Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | CES1 | P23141 | 3/20 | 0.42 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | XBP1 | P17861 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1898420 | 0.81 | KMT2A (0.52) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL79975 | 0.81 | KMT2A (0.52) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL6418982 | 0.81 | KMT2A (0.52) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL434262 | 0.81 | CYP2C19 (0.43) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL291408 | 0.81 | CYP2C19 (0.43) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL11230433 | 0.79 | CYP2C19 (0.42) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL560689 | 0.79 | CES2 (0.43) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL5189613 | 0.79 | KMT2A (0.55) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL1712503 | 0.77 | KMT2A (0.46) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL61242 | 0.75 | MEN1 (0.68) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 523 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150024428-A1 | METHOD OF IDENTIFICATION OF SPORE-FORMING Bacillus spp. BY DIRECT In-situ ANALYSIS OF MALDI-TOF MASS SPECTROMETRY, AND ANALYSIS SYSTEM | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2015-01-22 | — | — | US | claimed |
| US-8525104-B2 | Methods for direct biomolecule identification by matrix-assisted laser desorption ionization (MALDI) mass spectrometry | NEW YORK UNIVERSITY (US) | 2013-09-03 | — | — | US | claimed |
| US-20110062320-A1 | Methods for direct biomolecule identification by matrix-assisted laser desorption ionization (MALDI) mass spectrometry | NEW YORK UNIVERSITY | 2011-03-17 | — | — | US | claimed |
| US-7847245-B2 | Multiplexing matrix-analyte stereo electronic interactions for high throughput shotgun metabolomics | PLATOMICS, INC. (US) | 2010-12-07 | — | — | US | claimed |
| US-7781731-B2 | Method and apparatus for qualitatively analyzing high-molecular additives in metal plating solution | SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) | 2010-08-24 | — | — | US | claimed |
| US-7714276-B2 | Methods for direct biomolecule identification by matrix-assisted laser desorption ionization (MALDI) mass spectrometry | NEW YORK UNIVERSITY (US) | 2010-05-11 | — | — | US | claimed |
| US-20090278041-A1 | Method and apparatus for qualitatively analyzing high-molecular additives in metal plating solution | SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) | 2009-11-12 | — | — | US | claimed |
| US-20090065687-A1 | MULTIPLEXING MATRIX-ANALYTE STEREO ELECTRONIC INTERACTIONS FOR HIGH THROUGHPUT SHOTGUN METABOLOMICS | PLATOMICS, INC. | 2009-03-12 | — | — | US | claimed |
| US-7449150-B2 | Probe and apparatus for desorption and ionization of analytes | BAYLOR COLLEGE OF MEDICINE (US) | 2008-11-11 | — | — | US | claimed |
| US-7413909-B2 | Method and apparatus for desorption and ionization of analytes | BAYLOR COLLEGE OF MEDICINE (US) | 2008-08-19 | — | — | US | claimed |
| WO-2007041520-A9 | METHODS FOR DIRECT PROTEIN IDENTIFICATION BY MALDI | UNIV NEW YORK (US) | 2007-08-30 | — | — | WO | claimed |
| US-20070114375-A1 | Methods for direct biomolecule identification by matrix-assisted laser desorption ionization (MALDI) mass spectrometry | NEW YORK UNIVERSITY | 2007-05-24 | — | — | US | claimed |
| WO-2007041520-A2 | METHODS FOR DIRECT PROTEIN IDENTIFICATION BY MALDI | NEW YORK UNIVERSITY (US) | 2007-04-12 | — | — | WO | claimed |
| US-20040238738-A1 | Method and apparatus for desorption and ionization of analytes | HUTCHENS T WILLIAM (US) | 2004-12-02 | — | — | US | claimed |
| EP-1347493-A9 | Method and apparatus for desorption and ionization of analytes | BAYLOR COLLEGE OF MEDICINE (US) | 2003-12-17 | — | — | EP | claimed |
| EP-1347493-A2 | Method and apparatus for desorption and ionization of analytes | BAYLOR COLLEGE OF MEDICINE (US) | 2003-09-24 | — | — | EP | claimed |
| US-6124137-A | APPARATUS FOR DETECTING AN ANALYTE IMMOBILIZED TO A SURFACE; FOR RECEPTIVITY DIRECTED DETECTION OF BIOPLOYMERS; FOR SEQUENCING BIOPOLYMERS | BAYLOR COLLEGE OF MEDICINE (US) | 2000-09-26 | — | — | US | claimed |
| US-5894063-A | Surface-enhanced neat desorption for disorption and detection of analytes | BAYLOR COLLEGE OF MEDICINE (US) | 1999-04-13 | — | — | US | claimed |
| US-20260137818-A1 | HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | NUCLIDIUM AG (CH) | 2026-05-21 | — | — | US | disclosed |
| US-5894063-A | Surface-enhanced neat desorption for disorption and detection of analytes | BAYLOR COLLEGE OF MEDICINE (US) | 1999-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137818-A1 | HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | FAP, SSTR1, PSMA1 | CYP2C19 3179/4885CYP1A2 4754/4885CYP2C9 3549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.